We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Webinars

Now get all the training you need – all in one place, and all for one low price!

The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.

PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!

If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $1,297

Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

Webinar Training Pass

Pharmaceutical Expedited Pathways: What Regulatory, Compliance and Quality Professionals Need to Know
72 minutes

Recorded on: Jan. 26, 2023

Description: Two lawyers in Ropes & Gray’s Life Sciences Regulatory and Compliance practice — Kellie Combs and Sarah Blankstein — share what you must know about qualifying criteria, what data or other information the FDA may expect, when to initiate discussions with the agency and best practices for securing the benefits, explaining:

  • The meaning of key terms, including “serious condition,” “available therapies” and “unmet medical need”;
  • Eligibility criteria, including data-generation requirements;
  • Timing and content considerations for designation requests and applications for expedited approval programs; and
  • How to qualify for multiple programs.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Kellie Combs, Partner, Ropes & Gray; and Sarah Blankstein, Counsel, Ropes & Gray

Run More Efficient, More Diverse Decentralized Clinical Trials: How Mobile Nursing Can Transform Your Research
55 minutes

Recorded on: Jan. 24, 2023

Description: Ellen Weiss — PCM Trials’ vice president, in-home solutions, decentralized clinical trials — explains how deploying a team of properly trained mobile research nurses can transform your remote trials, making them more efficient and more diverse, while improving participant retention. You’ll understand:

  • Which qualifications mobile research nurses must have for the biggest trial efficiencies and benefits;
  • Which specific activities they are authorized to carry out in the patient’s home;
  • The specialized training mobile research nurses must have; and
  • How to ensure adherence to good clinical practice (GCP) and constraint-induced therapy (CIT) when using a mobile nursing workforce.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Ellen Weiss, Vice President, In-Home Solutions, Decentralized Clinical Trials, PCM Trials

Manufacturing Quality: Using Audit Observations to Predict Problems
120 minutes

Recorded on: Jan. 19, 2023

Description: Susan Schniepp moderates a discussion with four of the most respected professionals in the field that takes a deep dive into the most important issues faced in developing and effectively utilizing world-class audits. They discuss:

  • How to use a risk-based approach to audits;
  • The importance of quality culture and regulatory requirements identifying quality culture;
  • Steps to take when a quality issue is identified through the audit process; and
  • The best practices for documenting and tracking resolutions to identified issues.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Susan Schniepp, Distinguished Fellow, Regulatory Compliance Associates; Seyed Khorashahi, Executive Vice President of Medical Device and CTO, Regulatory Compliance Associates; Steve Lynn, Executive Vice President of Pharmaceuticals; Michael de la Torre, CEO, Redica Systems

30 Days to A Future-Ready QMS: All While Saving Money and Staying Compliant!
59 minutes

Recorded on: Jan. 18, 2023

Description: Mickey Landkof, general manager and global vice president of sales for Dot Compliance, shares how to choose the right QMS software system for your company and use industry best practices to get it up and running in 30 days. He clarifies:

  • Why it takes so long for traditional QMS solutions to go live;
  • The steps required for a 30-day QMS implementation;
  • How to save time, money and resources, and decrease time to market by doing away with fully customized QMS solutions; and
  • How to build a future-ready strategy.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Mickey Landkof, General Manager and Global Vice President of Sales, Dot Compliance

FDA Pathways to Bring your Medical Device to Market: What Regulatory Professionals Need to Know
75 minutes

Recorded on: Jan. 17, 2023

Description: Shelly Garg, president and founder of the FDA regulatory compliance law firm Garg Law, explains the device marketing requirements and the various benefits, challenges and drawbacks associated with different regulatory pathways. She shares:

  • How a device is classified by the FDA;
  • How to determine whether your company’s product is a medical device and how the FDA intends to classify and regulate it;
  • Features, benefits, challenges and drawbacks of device marketing pathways, including premarket notification (510(k)), Premarket Approval (PMA), De Novo, Humanitarian Device Exemption (HDE) and Custom Device Exemption (CDE); and
  • Best practices and what the FDA is looking for in each pathway approach.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Shelly Garg, President and Founder, Garg Law

Beginning with the End in Mind: Inspection Readiness — A Sponsor’s Perspective
52 minutes

Recorded on: Dec. 15, 2022

Description: Donna Dorozinsky shares a strategy for identifying key parts that represent your study’s unique inspection risks, what you can do now to become more inspection prepared and the key processes you can put into place at study start-up so you’re continually inspection-prepared. You’ll learn:

  • How to identify key study activities where inspection risk may exist;
  • An approach that allows you to understand your study’s story even if you were not a participant in the management of the study;
  • How to identify key processes to put in place at study start-up to ensure that inspection preparation is integral to routine business; and
  • Ideas for better inspection preparation.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Donna Dorozinsky, President and CEO, Just in Time GCP

Gene & Cell Therapy Regulation: Comparability and Other New Developments
90 minutes

Recorded on: Dec. 14, 2022

Description: This webinar enables you to understand and comply with the FDA’s requirements and avoid common errors, so you can maintain your products’ critical quality attributes (CQAs) and bring them to market. You’ll learn:

  • FDA requirements for comparability studies for gene and cell therapy products;
  • Best practices for risk analysis and mitigation using comparability studies;
  • How to design an effective comparability protocol for a gene or cell therapy product;
  • How to construct a statistical approach to comparability; and
  • How to assemble the comparability package to comply with FDA requirements.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Scott R. Burger, MD, Principal, Advanced Cell & Gene Therapy; and William E. Janssen, PhD, Principal, WEJ Cell and Gene Therapy Consulting Services

Building a World-Class Regulatory Intelligence and Support System: What Regulatory, Compliance and Quality Professionals Need to Know
63 minutes

Recorded on: Dec. 13, 2022

Description: Dennett Kouri and Faviola Michelot detail how to build a regulatory intelligence management system that will enable you to stay ahead of the changes and stay compliant, sharing:

  • What regulatory intelligence is and how you can develop and implement it;
  • What resources are needed to support regulatory intelligence;
  • The new regulatory trends you must have on your radar; and
  • How to pursue engaging opportunities with regulators.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Dennett Kouri, Senior Vice President, Edwards Lifesciences; and Faviola Michelot, Senior Director, Edwards Lifesciences

Engaging with the FDA: Best Practices for Dealing with Warning Letters, Seizures, Injunctions — and More
68 minutes

Recorded on: Dec. 1, 2022

Description: Steve Silverman, president of The Silverman Group — and previous director of the Center for Devices and Radiological Health’s (CDRH) Office of Compliance and assistant director of the Center for Drug Evaluation and Research’s (CDER) Office of Compliance — shares how to engage effectively with the FDA. He’ll cover:

  • What effective FDA regulatory engagement means as well as misperceptions to be aware of;
  • The four essential principles of effective regulatory engagement: informed, trust-based, timely, appropriate;
  • The three steps to achieve effective regulatory engagement; and
  • How novel issues like digital technology and real-world evidence influence effective regulatory engagement.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Steve Silverman, President, The Silverman Group

The Unification Impact: The Unique Benefits of One System that Replaces Many
50 minutes

Recorded on: Nov. 30, 2022

Description: Take control of compliance and data integrity to accelerate research and development from drug discovery to clinical processes through a unified compliance management solution. Learn how to:

  • Unify and connect disparate systems and processes together within your quality and compliance system to mitigate risks and increase efficiencies; and
  • Integrate total compliance, quality, and risk management system that will not only replace 10–12-point solutions into one unified solution but also provides a collaborative environment that saves time and speeds up product launches.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Anu Ganguly, Senior Director, Strategic Client Partner, Xybion; and James Castonguay, Assistant Vice President, Product Development, Xybion

Previous 1 2 3 4 5 6 7 8 9 … 75 76 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Updates Smiths Medical CADD System Recall to Class I

  • Eisai’s New Alzheimer’s Drug Leqembi Hits the U.S. Market

  • Boston Scientific’s Single Use Ureteroscope Gets FDA Clearance

  • Gilead’s Trodelvy Gets Expanded Approval in Breast Cancer

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing